“…Moreover, circulating DNA has assumed clinical importance because of its association with several human disorders and, in particular, with the immune complex nephritis accompanying SLE, in which, in combination with anti‐DNA antibody, it appears to play an etiologic role 2. In addition, reports have suggested that anti‐DNA antibody might be found not only in SLE, but also in the serum of patients with severe shock, thus becoming a prognostic marker 12,20. The possibility that DNA antibodies can prevent the formation of messenger RNA, or otherwise block the mechanism of protein synthesis during shock, points to the therapeutic use of nucleotides for inhibiting these potential antibody effects 20…”